Plain-English translation of NCT04064177 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to see if a special non-invasive monitor can accurately measure how well a newborn's heart is working. The study will track healthy newborns and sick babies in the neonatal intensive care unit over 3 years to understand normal heart function and how treatments like fluids and medications affect the baby's heart.
Doctors currently lack a simple, safe way to continuously monitor how well a newborn's heart is pumping blood without using invasive tubes or catheters. This trial aims to validate a non-invasive tool that could help doctors better care for sick newborns and understand what normal heart function looks like in babies of different ages.
If your baby is enrolled, doctors will place a small non-invasive probe on the skin to continuously monitor heart function — no needles or tubes required. Healthy newborns may have one measurement in the first few days of life, while babies in intensive care may have ongoing monitoring to track how their heart responds to treatments like fluids, breathing support, and medications.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United Kingdom
Enrollment target
~148 participants
Started
October 2019
Primary completion
December 2024
Age range
1 Hour – 40 Weeks
Last updated on clinicaltrials.gov in July 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jayanta Banerjee Imperial College Healthcare NHS Trust
Neonatal consultant